Journals / Journal of the Turkish-German Gynecological Association / 2018 / Cilt: 19 - Sayı: 3

Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases

Pages
132–136
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The recognition of morphologic and immunohistochemical features of this newly described entity is crucialbecause it alters treatment and prognosis. (J Turk Ger Gynecol Assoc 2018; 19: 132-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Dedifferentiated endometrioid adenocarcinoma is a recently defined uterine tumor composed of low-grade endometrioidadenocarcinoma and undifferentiated carcinoma.
📊
Key Findings & Data:Herein, we present clinicopathologic, morphologic, and immunohistochemical features of 5cases of dedifferentiated endometrioid adenocarcinoma.Material and Methods: All cases which were diagnosed as mixed endometrial adenocarcinoma (endometrioid+undifferentiated carcinoma)or dedifferentiated endometrioid adenocarcinoma between January 2008 and December 2014 were retrieved from the archives of our institution’spathology department.Results: The median age of the patients was 58 years.
💡
Conclusion & Impact:The recognition of morphologic and immunohistochemical features of this newly described entity is crucialbecause it alters treatment and prognosis. (J Turk Ger Gynecol Assoc 2018; 19: 132-6)
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Dedifferentiated endometrioid adenocarcinoma is a recently defined uterine tumor composed of low-grade endometrioidadenocarcinoma and undifferentiated carcinoma. Herein, we present clinicopathologic, morphologic, and immunohistochemical features of 5cases of dedifferentiated endometrioid adenocarcinoma.Material and Methods: All cases which were diagnosed as mixed endometrial adenocarcinoma (endometrioid+undifferentiated carcinoma)or dedifferentiated endometrioid adenocarcinoma between January 2008 and December 2014 were retrieved from the archives of our institution’spathology department.Results: The median age of the patients was 58 years. Polypoid growth pattern was seen in 3 patients and 2 were diagnosed at advanced stage.All patients received either external radiotherapy, brachytherapy, chemotherapy or an appropriate combination according to the stage. Onlyone patient died of the disease. Microscopically, there was a sharp demarcation between the two tumor components. The undifferentiatedcarcinoma component was composed of diffuse sheets of monomorphic cells lacking any differentiation. Focal pleomorphism and rhabdoidfeatures were also noted. The undifferentiated carcinoma component was variably positive for PAX-8, cytokeratin, EMA, estrogen receptor, andneuroendocrine markers.Conclusion: Misdiagnosis of undifferentiated carcinoma in dedifferentiated endometrioid adenocarcinoma as grade 3 endometrioidadenocarcinoma is not uncommon. The recognition of morphologic and immunohistochemical features of this newly described entity is crucialbecause it alters treatment and prognosis. (J Turk Ger Gynecol Assoc 2018; 19: 132-6)

🔖

Cite This Article

BEZİRCİOĞLU, İ., HAYRULLAH, L., EKİNCİ, N., ÖCAL, İ., YİĞİT, S. (2022). Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases. Journal of the Turkish-German Gynecological Association, Cilt: 19 - Sayı: 3, 132–136. https://ajindex.com/articles/567488

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Silva EG, Deavers MT, Bodurka DC, Malpica A. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol 2006; 25: 52-8.
  2. Silva EG, Deavers MT, Malpica A. Undifferentiated carcinoma of the endometrium: A review. Pathology 2007; 39: 134-8.
  3. Altrabulsi B, Malpica A, Deavers MT, Bodurka DC, Broaddus R, Silva EG. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 2005; 29: 1316-21.
  4. Abeler VM, Kjørstad KE, Nesland JM. Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases. Cancer 1991; 68: 98-105.
  5. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs. Fourth Edition. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs; 2014.
  6. Wu ES, Shih leM, Diaz-Montes TP. Dedifferentiated endometrioid adenocarcinoma: An under-recognized but aggressive tumor? Gynecol Oncol Case Rep 2013; 5: 25-7.
  7. Giordano G, D’Adda T, Bottarelli L, Lombardi M, Brigati F, Berretta R, et al. Two cases of low-grade endometrioid carcinoma associated with undifferentiated carcinoma of the uterus (dedifferentiated carcinoma): A molecular study. Pathol Oncol Res 2012; 18: 523-8.
  8. Berretta R, Patrelli TS, Faioli R, Mautone D, Gizzo S, Mezzogiorno A, et al. Dedifferentiated endometrial cancer: An atypical case diagnosed from cerebellar and adrenal metastasis: Case presentation and review of literature. Int J Clin Exp Pathol 2013; 6: 1652-7.
  9. Park SY, Park MH, Ko HS, Cha EJ, Sohn JS, Jung US, et al. Dedifferentiated endometrioid adenocarcinoma of the uterus: Highly aggressive and poor prognostic tumor. Korean J Pathol 2014; 48: 327-30.
  10. Shen Y, Wang Y, Shi Y, Liu J, Liu Y. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: A case report. Int J Clin Exp Pathol 2012; 5: 77-82.
  11. Onder S, Taskin OC, Sen F, Topuz S, Kucucuk S, Sozen H, et al. High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium: An immunohistochemical and clinicopathologic study. Medicine (Baltimore) 2017; 96: e6248. Stewart CJ, Crook ML. Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma. Hum Pathol 2015; 46: 1514-20.
  12. Li Z, Zhao C. Clinicopathologic and Immunohistochemical Characterization of Dedifferentiated End